134 related articles for article (PubMed ID: 11852373)
1. Micro- and macrovascular complications and hyperhomocysteinaemia in type 1 diabetic patients.
Buysschaert M; Jamart J; Dramais AS; Wallemacq P; Hermans MP
Diabetes Metab; 2001 Dec; 27(6):655-9. PubMed ID: 11852373
[TBL] [Abstract][Full Text] [Related]
2. Hyperhomocysteinemia in type 2 diabetes: relationship to macroangiopathy, nephropathy, and insulin resistance.
Buysschaert M; Dramais AS; Wallemacq PE; Hermans MP
Diabetes Care; 2000 Dec; 23(12):1816-22. PubMed ID: 11128359
[TBL] [Abstract][Full Text] [Related]
3. Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease.
Smulders YM; Rakic M; Slaats EH; Treskes M; Sijbrands EJ; Odekerken DA; Stehouwer CD; Silberbusch J
Diabetes Care; 1999 Jan; 22(1):125-32. PubMed ID: 10333913
[TBL] [Abstract][Full Text] [Related]
4. Plasma homocysteine and microvascular complications in type 1 diabetes.
Vaccaro O; Perna AF; Mancini FP; Iovine C; Cuomo V; Sacco M; Tufano A; Rivellese AA; Ingrosso D; Riccardi G
Nutr Metab Cardiovasc Dis; 2000 Dec; 10(6):297-304. PubMed ID: 11302003
[TBL] [Abstract][Full Text] [Related]
5. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
Chico A; Pérez A; Córdoba A; Arcelús R; Carreras G; de Leiva A; González-Sastre F; Blanco-Vaca F
Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051
[TBL] [Abstract][Full Text] [Related]
6. Plasmatic homocysteine concentration and its relationship with complications associated to diabetes mellitus.
Agulló-Ortuño MT; Albaladejo MD; Parra S; Rodríguez-Manotas M; Fenollar M; Ruíz-Espejo F; Tebar J; Martínez P
Clin Chim Acta; 2002 Dec; 326(1-2):105-12. PubMed ID: 12417101
[TBL] [Abstract][Full Text] [Related]
7. Relationship between metformin use, vitamin B12 deficiency, hyperhomocysteinemia and vascular complications in patients with type 2 diabetes.
Sato Y; Ouchi K; Funase Y; Yamauchi K; Aizawa T
Endocr J; 2013; 60(12):1275-80. PubMed ID: 24018893
[TBL] [Abstract][Full Text] [Related]
8. Plasma homocysteine levels in acute coronary syndromes.
Turgan N; Boydak B; Habif S; Apakkan S; Ozmen D; Mutaf I; Bayindir O
Jpn Heart J; 1999 Nov; 40(6):729-36. PubMed ID: 10737556
[TBL] [Abstract][Full Text] [Related]
9. [Correlation between plasma concentrations of homocysteine and diabetic polyneuropathy evaluated with the Semmes-Weinstein monofilament test in patients with type 2 diabetes mellitus].
Molina M; Gonzalez R; Folgado J; Real JT; Martínez-Hervás S; Priego A; Lorente R; Chaves FJ; Ascaso JF
Med Clin (Barc); 2013 Nov; 141(9):382-6. PubMed ID: 23332627
[TBL] [Abstract][Full Text] [Related]
10. Plasma homocysteine concentrations in patients with type 1 diabetes.
Cronin CC; McPartlin JM; Barry DG; Ferriss JB; Scott JM; Weir DG
Diabetes Care; 1998 Nov; 21(11):1843-7. PubMed ID: 9802731
[TBL] [Abstract][Full Text] [Related]
11. Plasma homocysteine levels in patients with type 2 diabetes in a Mediterranean population: relation with nutritional and other factors.
Diakoumopoulou E; Tentolouris N; Kirlaki E; Perrea D; Kitsou E; Psallas M; Doulgerakis D; Katsilambros N
Nutr Metab Cardiovasc Dis; 2005 Apr; 15(2):109-17. PubMed ID: 15871859
[TBL] [Abstract][Full Text] [Related]
12. Total homocysteine in patients with type 1 diabetes.
Pavía C; Ferrer I; Valls C; Artuch R; Colomé C; Vilaseca MA
Diabetes Care; 2000 Jan; 23(1):84-7. PubMed ID: 10857974
[TBL] [Abstract][Full Text] [Related]
13. Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2.
de Luis DA; Fernandez N; Arranz ML; Aller R; Izaola O; Romero E
J Diabetes Complications; 2005; 19(1):42-6. PubMed ID: 15642489
[TBL] [Abstract][Full Text] [Related]
14. Hyperhomocysteinemia in poorly controlled type 2 diabetes patients.
Drzewoski J; Czupryniak L; Chwatko G; Bald E
Diabetes Nutr Metab; 2000 Dec; 13(6):319-24. PubMed ID: 11232756
[TBL] [Abstract][Full Text] [Related]
15. Severe retinopathy in type 1 diabetic patients is not related to the level of plasma homocysteine.
Agardh E; Hultberg B; Agardh CD
Scand J Clin Lab Invest; 2000 May; 60(3):169-74. PubMed ID: 10885488
[TBL] [Abstract][Full Text] [Related]
16. Associations of plasma homocysteine concentration in subjects with type 2 diabetes mellitus.
Abdella NA; Mojiminiyi OA; Akanji AO; Moussa MA
Acta Diabetol; 2002 Dec; 39(4):183-90. PubMed ID: 12486492
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of hyperhomocysteinaemia, selected determinants and relation to hypertension severity in Northern-Nigerian hypertensives: the ABU homocysteine survey.
Onyemelukwe OU; Maiha BB
Ghana Med J; 2020 Mar; 54(1):17-29. PubMed ID: 32863409
[TBL] [Abstract][Full Text] [Related]
18. [Factors influencing homocysteineamia in type 2 diabetic patients].
Essais O; Bouzid C; Ouni Z; Ibrahim H; Ouertani H; Machghoul S; Zidi B
Tunis Med; 2006 May; 84(5):279-81. PubMed ID: 16915776
[TBL] [Abstract][Full Text] [Related]
19. Glycaemic control and microvascular complications in a large cohort of Italian Type 1 diabetic out-patients.
Lepore G; Bruttomesso D; Nosari I; Tiengo A; Trevisan R
Diabetes Nutr Metab; 2002 Aug; 15(4):232-9. PubMed ID: 12416660
[TBL] [Abstract][Full Text] [Related]
20. Homocysteine concentrations and vascular complications in patients with type 2 diabetes.
Rudy A; Kowalska I; Straczkowski M; Kinalska I
Diabetes Metab; 2005 Apr; 31(2):112-7. PubMed ID: 15959416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
